Retatrutide engages three receptors; semaglutide engages one. A structural and in-vitro receptor-pharmacology comparison for New Zealand research laboratories.
Retatrutide vs semaglutide compares the two ends of the incretin-receptor spectrum currently studied in peptide research: retatrutide is a triple GIP/GLP-1/glucagon receptor ligand, while semaglutide is a selective GLP-1 receptor mono-agonist. This reference is a structural and in-vitro pharmacology comparison only.
Retatrutide vs semaglutide: quick reference table
| Attribute | Retatrutide | Semaglutide |
|---|---|---|
| Receptors studied | GIP + GLP-1 + Glucagon | GLP-1 only |
| Length | 39 residues | 31 residues |
| Average mass | ~4731 Da | ~4113.6 Da |
| Backbone origin | GIP-derived, triple cross-reactive | GLP-1(7-37) analog |
Receptor pharmacology differences
- Retatrutide is studied across a three-receptor reporter panel: GIP-R, GLP-1R and GCG-R.
- Semaglutide is studied as a selective single-receptor ligand at the GLP-1 receptor only.
- Both use fatty-acid diacid conjugation strategies studied for reversible albumin association in stability assays.
- The additional glucagon-receptor cross-activity is unique to retatrutide among the two.
In-vitro assay comparison
| Assay focus | Retatrutide | Semaglutide |
|---|---|---|
| Receptor panel studied | GIP-R, GLP-1R, GCG-R | GLP-1R only |
| Reporter assay type | Parallel cAMP reporter panel | cAMP accumulation (GLP-1R line) |
| Plasma stability studies | Serum incubation + LC-MS | Serum incubation + LC-MS |
Analytical documentation expectations
- Batch identifier and synthesis date traceable to the lot record
- HPLC purity ≥98% (typically ≥99% for peptides under 30 residues)
- LC-MS confirmed monoisotopic or average mass within ±0.5 Da of theoretical
- Counterion identity and content (acetate or trifluoroacetate) reported
- Bacterial endotoxin and residual solvents per the analytical method
Sourcing research-grade retatrutide and semaglutide in New Zealand
Kiwi Peps supplies both retatrutide and semaglutide to the KP-99 Purity Standard (99%+ HPLC-MS), with batch records in The Batch Book and Bench-Ready Dispatch nationwide. Strictly for in-vitro research use only.
Frequently asked questions
What is the receptor-level difference between retatrutide and semaglutide?
Retatrutide is studied as a triple GIP/GLP-1/glucagon receptor agonist. Semaglutide is studied as a selective GLP-1 receptor agonist only.
How do the molecular weights compare?
Retatrutide has an average mass of approximately 4731 Da; semaglutide is approximately 4113.6 Da.
Which is the better reference ligand for GLP-1-only assays?
Semaglutide's selectivity for the GLP-1 receptor makes it the more targeted reference ligand where a single-receptor readout is required.
How does Kiwi Peps verify purity for both peptides?
Every batch is tested to the KP-99 Purity Standard (99%+ HPLC-MS) and published in The Batch Book.
